Actionable news
All posts from Actionable news
Actionable news in NURO: NeuroMetrix, Inc.,

NeuroMetrix Announces Issuance of a U.S. Patent for Core Technology in DPNCheck® Point-of-Care Neuropathy Test


NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,173,581. The patent covers the core technology deployed in the DPNCheck device. The claims cover the novel integrated design of the hand-held DPNCheck device that enables accurate and rapid measurement of sural nerve conduction, which is a standard neuropathy biomarker. Additional claims cover the automation algorithms and biosensors.

This patent...